Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Drug Development for Cancer and Diabetes -

Drug Development for Cancer and Diabetes

A Path to 2030
Buch | Softcover
362 Seiten
2022
Apple Academic Press Inc. (Verlag)
978-1-77463-493-6 (ISBN)
CHF 144,85 inkl. MwSt
Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases.
Key features include:










Details the role of plants for the treatment and management of cancer and diabetes







Discusses the role of phytocompounds as ligands for cancer and diabetic targets







Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs







Explores the green biosynthesis of nanoparticles and their treatment efficiency

K. Saravanan, PhD, is Associate Dean of Academic Affairs and Assistant Professor of Zoology, Nehru Memorial College, an affiliated institution of Bharathidasan University, Tamilnadu, India. He has been engaged in teaching, research, and writing for over 15 years. Chukwuebuka Egbuna is a chartered chemist, a chemical analyst, and an academic researcher. He has had many roles at New Divine Favor Pharmaceutical Industry Limited, Nigeria, and Chukwuemeka Odumegwu Ojukwu University, Nigeria. He has published research articles on phytochemistry as well as the 3-volume book Phytochemistry with AAP. Horne Iona Averal, PhD, is Associate Professor at Holy Cross College, Trichy, India. She has received many awards and honors and has been engaged with many academic roles at several colleges and universities. Dr. Averal has published four nucleotide sequences in the NCBI-GENBANK. S. Kannan, PhD, is a specialist in cancer biology and nanomedicine. He has held many roles at national and international academic and scientific bodies and has published a large number of research articles and books in his field. S. Elavarasi, PhD, is Assistant Professor at Holy Cross College, an affiliated institution of Bharathidasan University, Tamilnadu, India. She has been engaged in teaching and research for more than eight years. She has published research articles, book chapters, and books. Bir Bahadur, PhD, was formerly Professor, Chairman, and Head of the Department, as well as Dean of the Faculty of Science at Kakatiya University in Warangal, India. A prolific writer and editor, he received many awards and honors during his long career, including being named as an Eminent Botanist of India.

PART I CANCER AND LEADS FOR CANCER TREATMENT 1. Biomarkers for Screening of Premalignant Lesions and Therapeutic Surveillance 2. Kinase Targets in Cancer Drug Discovery 3. Essential Drug Properties and Stages in Anti-Cancer Drug Development 4. Plant Constituent as Anti-Cancer Drugs 5. Anticancer Properties of Some Effective Phytochemicals 6. Therapeutic Aspects of Some Extracts and Purified Cardiac Glycosides Obtained From Nerium oleander L 7. Challenging Compounds of Some Medicinal Plants Against Cancer 8. Medicinal Plants as Therapeutic Agents in the Treatment of Cancer 9. Cytotoxic, Apoptosis Inducing Effects and Anti-Cancerous Drug Candidature of Jasmonates 10. Apoptosis Activity of 1,2,-Benzene Dicarboxylic Acid Isolated from Andrographis paniculata on KB, SiHa and IMR Cancer Cell Line 11. Anticancer Drug Discovery From the Indian Spice Box 12. Phytochemical Investigation and Evaluation of Anti-Breast Cancer Activity of Chloroform Extract of Tagetes erecta 13. Isolation, Identification and In Silico Evaluation of Anticancer Activity of Flavone from Pisum sativum 14. Functional Lead Phytochemicals from the Rutaceae and Zingeiberaceae Plants for Development of Anticancer Drugs 15. In Vitro Anticancer Activity of Biophytum sensitivum on Liver Cancer Lines (HEPG2) 16. Saffron and Its Active Ingredients: A Natural Product with Potent Anticancer Property PART I: ANTIDIABETIC DRUG DISCOVERY 17. Effects of Pterocarpus marsupium in the Management of Type 2 Diabetes Mellitus 18. Antidiabetic and Antihyperlipidemic Activities of Cyathea nilgiriensis (Holttum) on STZ Induced Diabetic Rats 19. Antidiabetic Activity of Drug Loaded Chitosan Nanoparticle 20. Antidiabetic Activity of Silver Nanoparticles Biosynthesized Using Ventilago maderaspatana Leaf Extract 21. Hypoglycemic Activity of Biophytum sensitivum Whole Plant Extracts on Alloxan Induced Diabetic Rats 22. Antidiabetic Activity of Ventilago maderaspatana Leaf Extracts on STZ Induced Diabetic Rats 23. Isolation, Identification, and Molecular Docking of Antidiabetic Compounds of Cyatheia nilgiriensis (Holttum) 24. Antidiabetic Potentials of Major Indian Spices: A Review 25. Aloe Species: Chemical Composition and Therapeutic Uses in Diabetic Treatment

Erscheinungsdatum
Zusatzinfo 31 Tables, black and white; 13 Illustrations, color; 32 Illustrations, black and white
Verlagsort Oakville
Sprache englisch
Maße 156 x 234 mm
Gewicht 640 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Technik
ISBN-10 1-77463-493-7 / 1774634937
ISBN-13 978-1-77463-493-6 / 9781774634936
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95